To assess the benefits of turmeric, we compared results from multiple systematic reviews that review the literature.1,2,3,4,5,6,7 Turmeric has long been used in eastern medicine, but what do the randomized controlled trials say?
For metabolic syndrome, pre-diabetes, and type II diabetes, all systematic reviews we found show improvements in blood pressure, HbA1c levels, fat levels, cholesterol, and more.1,5,6,7. Each of these systematic reviews combined data from randomized controlled trials to find statistically significant reductions across these critical metabolic indicators.
For patients with osteoarthritis, pain and function was improved in a meta-analyses across 10 randomized controlled trials.1,8
Turmeric may even help reduce cognitive decline, but more research is needed in this area.2
Note that the Rolfe article has a conflict of interest. However, none of our claims are based on the Rolfe article alone, since other reviews support the same findings.
Patients with metabolic syndrome in multiple meta-analyses had a statistically significant reduction in blood pressure across pooled data from 7+ systematic reviews. (1,5) Other health indicators were improved as well across multiple meta-analyses, including triglyceride (fat) levels, BMI, waist circumference, total cholesterol, leptin, and others. (1,5,7)
Another meta-analysis found statistically significant positive impacts on BMI, weight, leptin levels, and adiponectin levels using data spanning 21 randomized controlled trials (6).
Source: Rolfe, 2020 (1). Azhdari, 2019 (5). Akbari, 2019 (6). Chien, 2021 (7)
Curcumin statistically significantly reduced pain and helped reinstate physical function / mobility in osteoarthritis patients when compared to placebo. Data was aggregated across 10 randomized controlled trials in Paultre (8) and seven systematic reviews in Rolfe (1).
Source: Rolfe, 2020 (1); Paultre, 2021 (8).
Patients with pre-diabetes or type 2 diabetes had a statistically significant reduction in HbA1C across pooled data from 12 systematic reviews.
Source: Rolfe, 2020 (1).
3 of 5 studies in healthy, non-demented elderly found either reduced cognitive decline or improved cognitive performance over time, relative to placebo
Source: Voulgaropoulou, 2019 (2).
23 systematic reviews reported no serious adverse events; 15 reviews detailed adverse events which were all minor and included GI symptoms (nausea, diarrhea), headaches, sleepiness, hypertension, etc.
Source: Rolfe, 2020 (1).